| Literature DB >> 25114675 |
Maryam Eftekhar1, Elham Rahmani2, Soheila Pourmasumi1.
Abstract
BACKGROUND: Frozen embryo transfer (FET) is one of the most important supplementary procedures in the treatment of infertile couples. While general information concerning the outcome of fresh embryo transfer has been documented, paucity of investigations has addressed the clinical factors influenced on pregnancy rates in FET.Entities:
Keywords: Clinical pregnancy rate; Frozen embryo transfer; In Vitro Fertilization
Year: 2014 PMID: 25114675 PMCID: PMC4126257
Source DB: PubMed Journal: Iran J Reprod Med ISSN: 1680-6433
Characteristics of patients studied
|
|
|
|---|---|
| Female age (year) | 30.22 ± 4.83 |
| Male age (year) | 39.4 ± 5.42 |
| Infertility duration (year) | 8.26 ± 4.41 |
| Basal FSH (IU/ml) | 6.8 ± 3.02 |
| Embryos transferred | 2.45 ± 0.75 |
Parameters expressed as mean±SE
The frequency distribution of pregnancy rate based on etiology of infertility in patients studied
|
|
|
|
|---|---|---|
| Male factor | 68 | 48.9 |
| Poly cystic ovary | 68 | 53.54 |
| Tubal factor | 8 | 47.1 |
| Endometriosis | 5 | 62.5 |
| Hypothalamic amenorrhea | 1 | 33.3 |
| Unexplained | 24 | 54.5 |
| Mixed | 20 | 5.37 |
| Total | 194 | 52.2 |
Parameters expressed as mean±SD or percentage as appropriate
Pregnancy rate based on clinical factors in patients studied
|
|
|
|
| |
|---|---|---|---|---|
| Female age | ||||
| <35 | 173 | 57.7 | 0.0001 | |
| >35 | 21 | 29.2 | ||
| Reason for embryo cryopreservation | ||||
| Preserve the excess embryos | 101 | 50.2 | 0.717 | |
| Preventing ovarian hyperstimulation | 91 | 54.5 | ||
| Endometrial insufficiency | 2 | 50 | ||
| Primary ovarian hyperstimulation protocol | ||||
| Agonist | 106 | 52.5 | 0.487 | |
| Antagonist | 88 | 51.8 | ||
| ART techniques | ||||
| IVF | 80 | 52.3 | 1.00 | |
| ICSI | 114 | 52.1 | ||
| Type of infertility | ||||
| Primary | 168 | 52 | 1.00 | |
| Secondary | 26 | 53.1 | ||
| FSH level | ||||
| >10 IU/ml | 187 | 56.3 | 0.0001 | |
| ≤10 IU/ml | 7 | 17.5 | ||
| Endometrial thickness | ||||
| <9 mm | 137 | 50.4 | 0.916 | |
| ≥ 9 mm | 57 | 57 | ||
| Duration of treatment | ||||
| <16 days | 118 | 52.4 | 0.916 | |
| ≥16 days | 76 | 51.7 | ||
Parameters expressed as mean±SD or percentage as appropriate.
Chi-square and Student’s t test were used.